Ezban M - Search Results

1

Locations of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor VIII (antihemophilic factor A).

McMullen BA, Fujikawa K, Davie EW, Hedner U, Ezban M. McMullen BA, et al. Among authors: ezban m. Protein Sci. 1995 Apr;4(4):740-6. doi: 10.1002/pro.5560040413. Protein Sci. 1995. PMID: 7613471 Free PMC article.

2

High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system.

Kjalke M, Ezban M, Monroe DM, Hoffman M, Roberts HR, Hedner U. Kjalke M, et al. Among authors: ezban m. Br J Haematol. 2001 Jul;114(1):114-20. doi: 10.1046/j.1365-2141.2001.02870.x. Br J Haematol. 2001. PMID: 11472355 Free article.

3

Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis.

Hedner U, Ezban M. Hedner U, et al. Among authors: ezban m. Annu Rev Med. 2008;59:29-41. doi: 10.1146/annurev.med.59.061606.095605. Annu Rev Med. 2008. PMID: 17845136 Review.

4

Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model.

Holst J, Kristensen AT, Kristensen HI, Ezban M, Hedner U. Holst J, et al. Among authors: ezban m. Eur J Vasc Endovasc Surg. 1998 Jun;15(6):515-20. doi: 10.1016/s1078-5884(98)80112-3. Eur J Vasc Endovasc Surg. 1998. PMID: 9659887 Free article.

5

Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis.

Arnljots B, Söderström T, Ezban M, Hedner U. Arnljots B, et al. Among authors: ezban m. Blood Coagul Fibrinolysis. 2000 Apr;11 Suppl 1:S145-8. doi: 10.1097/00001721-200004001-00027. Blood Coagul Fibrinolysis. 2000. PMID: 10850581

6

The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.

Kjalke M, Oliver JA, Monroe DM, Hoffman M, Ezban M, Hedner U, Roberts HR. Kjalke M, et al. Among authors: ezban m. Thromb Haemost. 1997 Oct;78(4):1202-8. Thromb Haemost. 1997. PMID: 9364985

7

Antithrombotic efficacy of inactivated active site recombinant factor VIIa is shear dependent in human blood.

Orvim U, Barstad RM, Orning L, Petersen LB, Ezban M, Hedner U, Sakariassen KS. Orvim U, et al. Among authors: ezban m. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3049-56. doi: 10.1161/01.atv.17.11.3049. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409292

8

Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats.

Lauritzen B, Hedner U, Johansen PB, Tranholm M, Ezban M. Lauritzen B, et al. Among authors: ezban m. J Thromb Haemost. 2008 May;6(5):804-11. doi: 10.1111/j.1538-7836.2008.02933.x. Epub 2008 Feb 25. J Thromb Haemost. 2008. PMID: 18315554 Free article.

9

Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa.

Arnljots B, Ezban M, Hedner U. Arnljots B, et al. Among authors: ezban m. J Vasc Surg. 1997 Feb;25(2):341-6. doi: 10.1016/s0741-5214(97)70356-2. J Vasc Surg. 1997. PMID: 9052569 Free article.

10

A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia.

Allen GA, Persson E, Campbell RA, Ezban M, Hedner U, Wolberg AS. Allen GA, et al. Among authors: ezban m. Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):683-9. doi: 10.1161/01.ATV.0000257204.82396.2b. Epub 2007 Jan 4. Arterioscler Thromb Vasc Biol. 2007. PMID: 17204663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters